Tamr Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research

January 24, 2019 |

2 min read

Tamr Inc. today announced it has joined Accenture’s open partner ecosystem, designed to help independent software vendors (ISVs) and life science companies team more effectively to accelerate drug discovery efforts and improve patient outcomes.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Tamr Inc. today announced it has joined Accenture’s open partner ecosystem, designed to help independent software vendors (ISVs) and life science companies team more effectively to accelerate drug discovery efforts and improve patient outcomes. The ecosystem is an integral part of Accenture’s cloud-based informatics research platform, which has been designed to help life sciences organizations improve productivity, efficiency, and innovation in drug discovery.

Accenture is currently working with Tamr and a select number of other ISVs and organizations to integrate their technology and content into Accenture’s research platform. The inclusion of Tamr’s technology will make it easier for life sciences companies to address challenging data unification issues that too often become bottlenecks in digital transformation initiatives. By applying Unify -- Tamr’s patented machine learning-based software platform -- to automate the unification of myriad data sources, users of Accenture’s research informatics platform will be freed from tedious data integration work and empowered to focus on finding new insights.

“The open partner ecosystem is one of the ways we’re bringing innovation to our clients through the Accenture research platform,” said Joe Donahue, a managing director in Accenture’s Life Sciences practice. “Tamr’s participation in this ecosystem and integration with the research platform will give users a new, efficient way to overcome the challenge of data variety. As a result, researchers will be able to focus more time on analytics and discovery, rather than data preparation, which will ultimately lead to better patient outcomes.”

Toffer Winslow, chief business officer at Tamr, said, “We enthusiastically support Accenture’s efforts to build an open ecosystem of partners to accelerate innovation for life sciences researchers. The challenge of unifying sources and delivering high-quality, complete, and timely data to the people who need it is a persistent obstacle to digital transformation efforts across industries and functions. By working with Accenture to integrate Tamr Unify with the Life Science Research Platform, we will help researchers overcome those obstacles so that they can focus on optimizing the drug discovery process.”

About Tamr, Inc.
Tamr is the enterprise-scale data unification company trusted by industry leaders like GE, Toyota, Thomson Reuters, and GSK. The company’s patented software platform uses machine learning supplemented with customers’ knowledge to unify and prepare data across myriad silos to deliver previously unavailable business-changing insights. With a co-founding team led by Andy Palmer (founding CEO of Vertica) and Mike Stonebraker (Turing Award winner) and backed by founding investors NEA and GV, Tamr is transforming how companies get value from their data.

Additional Resources:
· Learn more about Tamr: www.tamr.com
· Follow us on Twitter: https://twitter.com/Tamr_Inc
· Connect on LinkedIn: http://www.linkedin.com/company/tamr